Zivo Bioscience, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Traws Pharma, Inc.

Frequency Therapeutics, Inc.

VBI Vaccines, Inc.

GeoVax Labs, Inc.

Applied DNA Sciences, Inc.

Surrozen, Inc.

Longeveron, Inc.

Microbot Medical, Inc.

Zivo Bioscience, Inc.

CalciMedica, Inc.

BiomX, Inc.

Why is Zivo Bioscience, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

13.00%

EBIT Growth (5y)

-84.02%

EBIT to Interest (avg)

-6.44

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.13

Sales to Capital Employed (avg)

-0.07

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.69%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-40.58

EV to EBIT

-4.93

EV to EBITDA

-4.93

EV to Capital Employed

-46.55

EV to Sales

65.83

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -3.91 MM

NET SALES(HY)

At USD 0.05 MM has Grown at 49.5%

RAW MATERIAL COST(Y)

Fallen by -3,356% (YoY

PRE-TAX PROFIT(Q)

At USD -1.64 MM has Grown at 80.09%

NET PROFIT(Q)

At USD -1.64 MM has Grown at 80.09%

EPS(Q)

Highest at USD -0.43

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Zivo Bioscience, Inc.

Operating Cash Flow

Highest at USD -3.91 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales

At USD 0.05 MM has Grown at 49.5%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Pre-Tax Profit

At USD -1.64 MM has Grown at 80.09%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -1.64 MM has Grown at 80.09%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

EPS

Highest at USD -0.43

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by -3,356% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales